Spotlight on TAVR: Pivoting to the Low-Risk Population

Watch it now!

The FDA’s recent approval of EvolutTM TAVR for low-risk patients expands the use to potentially younger, more active patients signaling a significant shift in future treatment of symptomatic severe aortic stenosis. Learn from four leading cardiologists on the movement of TAVR into this low-risk patient population, how hospitals are increasing awareness among physicians and patients and the importance of connecting patients with heart teams.

Optimizing Relationships With Value-Minded Referring Physicians: 5 Things Radiologists Need to Know

5things.jpg

Just as changing circumstances impact how marriage partners work together for the sake of their families, new wrinkles in familiar processes affect the way radiologists and referring physicians cooperate for the good of their patients. And the “changing circumstances” and “new wrinkles” now include the strain of U.S. healthcare’s push for value-based care.